NASDAQ:BSTC BioSpecifics Technologies (BSTC) Stock Price, News & Analysis → Top Stock Unveiled! (From Darwin) (Ad) Free BSTC Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$88.53▼$88.5350-Day Range$88.22▼$88.5352-Week Range$42.00▼$89.15VolumeN/AAverage Volume61,105 shsMarket Capitalization$650.25 millionP/E Ratio37.51Dividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get BioSpecifics Technologies alerts: Email Address Ad DarwinTop Stock Unveiled!Ready to discover the standout stock of 2024? We’ve identified a single buy & hold gem that’s poised to redefine your portfolio. Download our exclusive report now and dive into the Insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.Get Your Free Report About BioSpecifics Technologies Stock (NASDAQ:BSTC)BioSpecifics Technologies Corp., a biopharmaceutical company, develops an injectable collagenase clostridium histolyticum for various indications in the United States and internationally. The company offers injectable collagenase for the treatment of Dupuytren's contracture and Peyronie's disease under the XIAFLEX and Xiapex brands. It also provides injectable collagenase to treat frozen shoulder, cellulite, canine lipoma, lateral hip fat, plantar fibromatosis, human lipoma, and uterine fibroids. The company has a development and license agreement with Endo Global Ventures. BioSpecifics Technologies Corp. was founded in 1957 and is headquartered in Wilmington, Delaware.Read More Ad DTITake a look at this candlestick chart.It doesn’t matter if the stock market eventually drops… Because once these Automated Options hit their goal - they’re set to automatically close the trade, and put us in cash… Sweet, sweet cash. Of course, no strategy wins all of the time… There will be winners and losers along the road - luckily this method is designed with a remarkable 76.9% win rate over the last five years according to the backtesting… That means it would have survived in TWO bull markets…Click here to catch the next Automated Option BSTC Stock News HeadlinesMarch 21, 2023 | bizjournals.comSilicon Valley Technology NewsSee More Headlines Receive BSTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioSpecifics Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/14/2020Today6/17/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryBiotechnology Current SymbolNASDAQ:BSTC CUSIP09093110 CIK875622 Webwww.biospecifics.com Phone302-842-8450FaxN/AEmployees7Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$3.33 Trailing P/E Ratio37.51 Forward P/E Ratio61.91 P/E GrowthN/ANet Income$24.47 million Net Margins47.43% Pretax MarginN/A Return on Equity14.81% Return on Assets14.46% Debt Debt-to-Equity RatioN/A Current Ratio66.24 Quick Ratio66.24 Sales & Book Value Annual Sales$38.19 million Price / Sales17.03 Cash Flow$3.38 per share Price / Cash Flow26.18 Book Value$18.42 per share Price / Book4.81Miscellaneous Outstanding Shares7,345,000Free FloatN/AMarket Cap$650.25 million OptionableNot Optionable Beta0.24 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report Key ExecutivesDr. Ronald Law J.D. (Age 67)Ph.D., Sr. VP of Bus. Devel. Comp: $487.38kMr. Joseph Truitt (Age 55)CEO & Director Mr. Patrick C. Hutchison (Age 61)Chief Financial Officer Mr. Alex MonteithSr. VP & Chief Bus. OfficerCarl A. ValensteinCorp. Sec.Key CompetitorsSinovac BiotechNASDAQ:SVAStemline TherapeuticsNASDAQ:STMLAkouosNASDAQ:AKUSAlbireo PharmaNASDAQ:ALBOCollegium PharmaceuticalNASDAQ:COLLView All Competitors BSTC Stock Analysis - Frequently Asked Questions How were BioSpecifics Technologies' earnings last quarter? BioSpecifics Technologies Corp. (NASDAQ:BSTC) issued its earnings results on Saturday, November, 14th. The biopharmaceutical company reported $0.89 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.19 by $0.70. The biopharmaceutical company earned $11.26 million during the quarter, compared to analysts' expectations of $5.46 million. BioSpecifics Technologies had a net margin of 47.43% and a trailing twelve-month return on equity of 14.81%. What other stocks do shareholders of BioSpecifics Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other BioSpecifics Technologies investors own include AbbVie (ABBV), NVIDIA (NVDA), Pfizer (PFE), Biogen (BIIB), Johnson & Johnson (JNJ), Horizon Therapeutics Public (HZNP), Inovio Pharmaceuticals (INO), Intel (INTC), Bristol-Myers Squibb (BMY) and CRISPR Therapeutics (CRSP). This page (NASDAQ:BSTC) was last updated on 6/17/2024 by MarketBeat.com Staff From Our PartnersTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored(Free Workshop) Advanced “bug-out bag” hacks!“Do you have a ‘bug-out bag’ (survival kit) ready to grab-and-go when a disaster or other crisis strikes?” ...Warrior Life | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the ...Crypto 101 Media | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioSpecifics Technologies Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioSpecifics Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.